Advertisement
Loading...

Ascletis Pharma Inc.

ASCLF•PNK
Healthcare
Biotechnology
$1.67
$-0.47(-22.04%)
U.S. Market is Open • 15:52

Ascletis Pharma Inc. (ASCLF) Stock Overview

Explore Ascletis Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-31.25
EPS (TTM)$-0.05
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$2.20
3 Months$2.31
1 Year Target$2.88

ASCLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ascletis Pharma Inc. (ASCLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 22.46, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $2.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.25 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-22.04%
5-Day Change
-21.96%
1-Month Change
-20.48%
3-Month Change
-25.11%
6-Month Change
-5.65%
Year-to-Date (YTD) Change
12.08%
1-Year Change
96.98%
3-Year Change
384.76%
5-Year Change
417400.00%
All-Time (Max) Change
178.33%

Contact Information

https://www.ascletis.com
86 571 8538 9730
Building D, Hangzhou, NaN, NaN

Company Facts

231 Employees
IPO DateNov 19, 2019
CountryCN
Actively Trading

Frequently Asked Questions